Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 114(24): E4772-E4781, 2017 06 13.
Article in English | MEDLINE | ID: mdl-28559342

ABSTRACT

Embryo implantation remains a significant challenge for assisted reproductive technology, with implantation failure occurring in ∼50% of in vitro fertilization attempts. Understanding the molecular mechanisms underlying uterine receptivity will enable the development of new interventions and biomarkers. TGFß family signaling in the uterus is critical for establishing and maintaining pregnancy. Follistatin (FST) regulates TGFß family signaling by selectively binding TGFß family ligands and sequestering them. In humans, FST is up-regulated in the decidua during early pregnancy, and women with recurrent miscarriage have lower endometrial expression of FST during the luteal phase. Because global knockout of Fst is perinatal lethal in mice, we generated a conditional knockout (cKO) of Fst in the uterus using progesterone receptor-cre to study the roles of uterine Fst during pregnancy. Uterine Fst-cKO mice demonstrate severe fertility defects and deliver only 2% of the number of pups delivered by control females. In Fst-cKO mice, the uterine luminal epithelium does not respond properly to estrogen and progesterone signals and remains unreceptive to embryo attachment by continuing to proliferate and failing to differentiate. The uterine stroma of Fst-cKO mice also responds poorly to artificial decidualization, with lower levels of proliferation and differentiation. In the absence of uterine FST, activin B expression and signaling are up-regulated, and bone morphogenetic protein (BMP) signals are impaired. Our findings support a model in which repression of activin signaling by FST enables uterine receptivity by preserving critical BMP signaling.


Subject(s)
Decidua/physiology , Follistatin/physiology , Uterus/physiology , Animals , Disease Models, Animal , Embryo Implantation/physiology , Female , Fertilization in Vitro , Follistatin/deficiency , Follistatin/genetics , Humans , Infertility, Female/physiopathology , Inhibin-beta Subunits/metabolism , Male , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Pregnancy , Signal Transduction
2.
Dev Biol ; 426(2): 245-254, 2017 06 15.
Article in English | MEDLINE | ID: mdl-27364468

ABSTRACT

The dorsal ventral axis of vertebrates requires high BMP activity for ventral development and inhibition of BMP activity for dorsal development. Presumptive dorsal regions of the embryo are protected from the ventralizing activity of BMPs by the secretion of BMP antagonists from the mesoderm. Noggin, one such antagonist, binds BMP ligands and prevents them from binding their receptors, however, a unique role for Noggin in amphibian development has remained unclear. Previously, we used zinc-finger nucleases to mutagenize the noggin locus in Xenopus tropicalis. Here, we report on the phenotype of noggin mutant frogs as a result of breeding null mutations to homozygosity. Early homozygous noggin mutant embryos are indistinguishable from wildtype siblings, with normal neural induction and neural tube closure. However, in late tadpole stages mutants present severe ventral craniofacial defects, notably a fusion of Meckel's cartilage to the palatoquadrate cartilage. Consistent with a noggin loss-of-function, mutants show expansions of BMP target gene expression and the mutant phenotype can be rescued with transient BMP inhibition. These results demonstrate that in amphibians, Noggin is dispensable for early embryonic patterning but is critical for cranial skeletogenesis.


Subject(s)
Branchial Region/growth & development , Carrier Proteins/physiology , Xenopus Proteins/physiology , Xenopus/growth & development , Alleles , Animals , Body Patterning , Bone Morphogenetic Proteins/pharmacology , Bone Morphogenetic Proteins/physiology , Carrier Proteins/genetics , Cartilage/abnormalities , Cell Differentiation , Embryo, Nonmammalian/metabolism , Embryo, Nonmammalian/ultrastructure , Follistatin/deficiency , Follistatin/genetics , Gene Knockout Techniques , Glycoproteins/deficiency , Glycoproteins/genetics , Homozygote , Intercellular Signaling Peptides and Proteins/deficiency , Intercellular Signaling Peptides and Proteins/genetics , Larva , Mandible/abnormalities , Morpholinos/pharmacology , Skull/abnormalities , Xenopus/embryology , Xenopus Proteins/deficiency , Xenopus Proteins/genetics
3.
Proc Natl Acad Sci U S A ; 110(39): E3713-22, 2013 Sep 24.
Article in English | MEDLINE | ID: mdl-24019467

ABSTRACT

Myostatin (MSTN) and growth and differentiation factor-11 (GDF-11) are highly related TGF-ß family members that have distinct biological functions. MSTN is expressed primarily in skeletal muscle and acts to limit muscle growth. GDF-11 is expressed more widely and plays multiple roles, including regulating axial skeletal patterning during development. Several MSTN and GDF-11 binding proteins have been identified, including GDF-associated serum protein-1 (GASP-1) and GASP-2, which are capable of inhibiting the activities of these ligands. Here, we show that GASP-1 and GASP-2 act by blocking the initial signaling event (namely, the binding of the ligand to the type II receptor). Moreover, we show that mice lacking Gasp1 and Gasp2 have phenotypes consistent with overactivity of MSTN and GDF-11. Specifically, we show that Gasp2(-/-) mice have posteriorly directed transformations of the axial skeleton, which contrast with the anteriorly directed transformations seen in Gdf11(-/-) mice. We also show that both Gasp1(-/-) and Gasp2(-/-) mice have reductions in muscle weights, a shift in fiber type from fast glycolytic type IIb fibers to fast oxidative type IIa fibers, and impaired muscle regeneration ability, which are the reverse of what are seen in Mstn(-/-) mice. All of these findings suggest that both GASP-1 and GASP-2 are important modulators of GDF-11 and MSTN activity in vivo.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Carrier Proteins/metabolism , Growth Differentiation Factors/metabolism , Myostatin/metabolism , Receptors, G-Protein-Coupled/metabolism , Animals , Body Patterning/genetics , Bone Morphogenetic Proteins/antagonists & inhibitors , Bone Morphogenetic Proteins/deficiency , Bone and Bones/embryology , Bone and Bones/metabolism , Cardiotoxins , Carrier Proteins/genetics , Follistatin/deficiency , Follistatin/metabolism , Gene Expression Profiling , Gene Expression Regulation , Growth Differentiation Factors/antagonists & inhibitors , Growth Differentiation Factors/deficiency , Intracellular Signaling Peptides and Proteins , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/pathology , Mutation/genetics , Myostatin/antagonists & inhibitors , Myostatin/genetics , Organ Size , Oxidation-Reduction , Protein Binding , Protein Serine-Threonine Kinases/metabolism , Receptor, Transforming Growth Factor-beta Type II , Receptors, G-Protein-Coupled/deficiency , Receptors, G-Protein-Coupled/genetics , Receptors, Transforming Growth Factor beta/metabolism , Regeneration/genetics , Signal Transduction/genetics
4.
Dev Dyn ; 230(2): 210-5, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15162500

ABSTRACT

Wnt4(-/-) XX gonads display features normally associated with testis differentiation, suggesting that WNT4 actively represses elements of the male pathway during ovarian development. Here, we show that follistatin (Fst), which encodes a TGFbeta superfamily binding protein, is a downstream component of Wnt4 signaling. Fst inhibits formation of the XY-specific coelomic vessel in XX gonads. In addition, germ cells in the ovarian cortex are almost completely lost in both Wnt4 and Fst null gonads before birth. Thus, we propose that WNT4 acts through FST to regulate vascular boundaries and maintain germ cell survival in the ovary.


Subject(s)
Follistatin/metabolism , Organogenesis , Ovary/embryology , Ovary/metabolism , Proto-Oncogene Proteins/metabolism , Animals , Apoptosis , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/metabolism , Female , Follistatin/antagonists & inhibitors , Follistatin/deficiency , Follistatin/genetics , Gene Expression Regulation, Developmental , Germ Cells/cytology , Germ Cells/metabolism , Mice , Mice, Knockout , Mutation/genetics , Ovary/cytology , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Wnt Proteins , Wnt4 Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...